Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- Ann-Marie Rosland
- Study ID
- NCT06848361
- Status
- Enrolling By Invitation
Conditions
- Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- MPowerHub — DEVICEThe MPowerHub app allows participants to visualize combined trends from a continuous glucose monitor (CGM) and activity monitor as well as daily self-reports in a display that the participant can customize to overlay the behavioral data they would like to compare to intraday and daily glucose data. Summary data will be displayed over time to allow users to identify potential associations between activity, sleep, stress, diet, and medication adherence and time-in-range and blood glucose variability. Participants receive daily prompts to complete five brief questions about daily health behaviors and two weekly goals/action plans and reflections based on motivational interviewing principles.
- Continuous Glucose Monitor (CGM) — DEVICEA CGM is a wearable device that collects frequent data on glucose levels. It includes an integrated sensor that is inserted under the skin and is connected to a small transmitter that automatically sends information to a smart device, allowing the user to track changes in glucose levels.
- Activity Monitor — DEVICEA wearable activity monitor will be used to track activity (e.g., steps) and sleep levels. Data can be viewed on the activity monitor or a smart device.
Study Details
Day-to-day self-management by adults with type 2 diabetes, including glucose monitoring, taking medications, and healthy habits, is essential to avoid diabetes complications, yet, despite the rapidly expanding availability of wearable glucose and activity monitors, successful self-management remains challenging for many. This research aims to develop and test an approach to help adults use their personal diabetes information from wearable devices to achieve and sustain health diabetes self-management, which will reduce diabetes complications, and improve health and quality of life for people with type 2 diabetes.
Key Dates
- Start date
- Apr 28, 2025
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: MPowerHubParticipants will: 1. Meet with a Diabetes Care and Education Specialist for an initial diabetes self-management education session that will include individualized assessment, education, and coaching on how to set personal diabetes self-management behavior goals and action plans, and follow-up education as needed. 2. Be trained on how to use assigned study devices (MPowerHub, continuous glucose monitor (CGM), and activity tracker). 3. Be asked to use assigned study devices (MPowerHub, CGM, and activity tracker) for 4 months.
- Active Comparator: Continuous Glucose Monitor (CGM) OnlyParticipants will: 1. Meet with a Diabetes Care and Education Specialist for an initial diabetes self-management education session that will include individualized assessment, education, and coaching on how to set personal diabetes self-management behavior goals and action plans, and follow-up education as needed. 2. Be trained on how to use assigned study device (CGM). 3. Be asked to use assigned study device (CGM) for 4 months.
- Active Comparator: Activity Monitor OnlyParticipants will: 1. Meet with a Diabetes Care and Education Specialist for an initial diabetes self-management education session that will include individualized assessment, education, and coaching on how to set personal diabetes self-management behavior goals and action plans, and follow-up education as needed. 2. Be trained on how to use assigned study device (activity tracker). 3. Be asked to use assigned study device (activity tracker) for 4 months.
Primary Outcome Measure
Percent of eligible individuals who enroll in the study [ Time Frame: Pre-baseline ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | - |
Find similar trials in Pittsburgh, PA
Related Studies
- CGM for Management of Type 2 Diabetes in PregnancyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- The GRoceries Aimed at Increasing Nutrition StudyRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational DiabetesRecruiting · Thomas Jefferson University · Sewell, New Jersey
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)PHASE2 · Recruiting · University of Florida · Gainesville, Florida